Journals / Dicle Tıp Dergisi / 2006 / Cilt: 33 - Sayı: 1

Methabolic evaluation and medical aspects of recurrent urinary tract calcium stones

Tekrarlayan üriner sistem kalsiyum taşlarının metabolik değerlendirilmesi ve medikal yaklaşımlar

Pages
48–52
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When dietary modification is unsuccessful in controlling stone formation or in the presence of severe metabolic derangements, a pharmacologic treatment may be necessary.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recurrent Stone formation in the urinary tract is a common and important problem.
📊
Key Findings & Data:Unfortunately a significant proportion of patients with recurrent stones do not undergo proper metabolic evaluation.
💡
Conclusion & Impact:When dietary modification is unsuccessful in controlling stone formation or in the presence of severe metabolic derangements, a pharmacologic treatment may be necessary.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kalsiyum okzalat · Üriner taş · Calcium Oxalate

Abstract

Recurrent Stone formation in the urinary tract is a common and important problem. The most important component in the medical treatment of stones is establishing the correct metabolic diagnosis. Unfortunately a significant proportion of patients with recurrent stones do not undergo proper metabolic evaluation. Dietary modification still remains one of the most important strategies for therapy. Recent studies suggest that severe calcium restriction is not useful in patients with recurrent calcium nephrolithiasis. New studies imply the significant role of oxalate, salt and animal protein dietary restrictions in the prevention of calcium stone recurrence. When dietary modification is unsuccessful in controlling stone formation or in the presence of severe metabolic derangements, a pharmacologic treatment may be necessary.

Özet

Üriner traktus’ta tekrarlayan taşların oluşumu önemli ve yaygın bir problemdir. Taşların medikal tedavisindeki en önemli faktör, doğru metabolik tanının konmasıdır. Maalesef, tekrarlayan taş hastalarının önemli bir kısmında uygun metabolik değerlendirme yapılmamaktadır. Diyet düzenlemeleri, halen tedavinin en önemli kısımlarından birini oluşturmaktadır. Son yapılan çalışmalar, tekrarlayan kalsiyum taşı olan hastalarda kalsiyum kısıtlamasının faydalı olmadığını belirtmektedir. Yeni çalışmalar, tekrarlayan kalsiyum taşlarının önlenmesinde oksalat, tuz ve hayvansal proteinlerin kıstlanmasının önemine dikkat çekmektedir. Diyet düzenlemeleri ile taş oluşumu kontrol altına alınamadığında veya şiddetli metabolik düzensizlik bulunduğunda farmakolojik tedavi gerekli olabilmektedir.

🔖

Cite This Article

ATUĞ, F., CANORUÇ, N. (2006). Methabolic evaluation and medical aspects of recurrent urinary tract calcium stones. Dicle Tıp Dergisi, Cilt: 33 - Sayı: 1, 48–52. https://ajindex.com/articles/349922

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Menon M, Resnick MI. Urinary lithiasis: etiology, diagnosis, and medical management. In: WalshPC, RetikAB, Vaughan ED, editors. Campbell's Urology Philadelphia: WB Saunders; p: 2002;3229-3305 2. Clinical approach. In: Coe FL, Parks JH, eds. Nephrolithiasis: pathogenesis and treatment (2nd edn), Chicago: Year Book Medical, p: 1998;1-37 3. Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet, 2001; 25;358 (9282): 651-656 4. Goldfarb DS., Coe FL. Prevention of recurrent nephrolithiasis. Am Fam Physician, 1999; 15;60:2269-2276 5. Mitch WE, Walser M. Nutritional therapy of the uremic patient. In Brenner BM, Rector FC Jr eds. The Kidney. Vol II. Third edn. Philadelphia: WB Saunders, 1986;1759-90. 6. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrence in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996;155:839-843. 7. Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron, 1999;81:31-37. 8. Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women. Ann Intern Med, 1998;128:534-540. 9. Soucie JM., Thun MJ., Coates RJ., et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int, 1994;46:893-899. 10. Prince CL, Scardino PL, Wolan TC. The effect of temperature, humidity, and dehydration on the formation of renal calculi. J Urol, 1956;75:209-212. 11. Curhan GC, Rimm EB, Willett WC, et al. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol, 1994;151:838-841. 12. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med, 1993;328:833-838 13. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med, 2002;346:77-84. 14. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med, 1997;126:497-504. 15. Pak CY, Peterson RD, Poindexter J. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol, 2002;168:31-34. 16. Asplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidn